Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 Minutes
- 10 August 2011
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (23), 3114-3119
- https://doi.org/10.1200/jco.2010.33.7071
Abstract
Purpose: We use changes in tumor measurements to assess response and progression, both in routine care and as the primary objective of clinical trials. However, the variability of computed tomography (CT) –based tumor measurement has not been comprehensively evaluated. In this study, we assess the variability of lung tumor measurement using repeat CT scans performed within 15 minutes of each other and discuss the implications of this variability in a clinical context. Patients and Methods: Patients with non–small-cell lung cancer and a target lung lesion ≥ 1 cm consented to undergo two CT scans within a period of minutes. Three experienced radiologists measured the diameter of the target lesion on the two scans in a side-by-side fashion, and differences were compared. Results: Fifty-seven percent of changes exceeded 1 mm in magnitude, and 33% of changes exceeded 2 mm. Median increase and decrease in tumor measurements were +4.3% and −4.2%, respectively, and ranged from 23% shrinkage to 31% growth. Measurement changes were within ± 10% for 84% of measurements, whereas 3% met criteria for progression according to Response Evaluation Criteria in Solid Tumors (RECIST; ≥ 20% increase). Smaller lesions had greater variability of percent measurement change (P = .005). Conclusion: Apparent changes in tumor diameter exceeding 1 to 2 mm are common on immediate reimaging. Increases and decreases less than 10% can be a result of the inherent variability of reimaging. Caution should be exercised in interpreting the significance of small changes in lesion size in the care of individual patients and in the interpretation of clinical trial results.Keywords
This publication has 21 references indexed in Scilit:
- Making the Investigational Oncology Pipeline More Efficient and Effective: Are We Headed in the Right Direction?Clinical Cancer Research, 2010
- Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variabilityEuropean Radiology, 2009
- Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2007
- Inherent Variability of CT Lung Nodule Measurements In Vivo Using Semiautomated Volumetric MeasurementsAmerican Journal of Roentgenology, 2006
- Pulmonary Metastases: Effect of CT Section Thickness on Measurement—Initial ExperienceRadiology, 2005
- Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer‐assisted techniquesMedical Physics, 2004
- Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor ResponseJournal of Clinical Oncology, 2003
- Evaluation of Tumor Measurements in Oncology: Use of Film-Based and Electronic TechniquesJournal of Clinical Oncology, 2000
- Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer.Journal of Clinical Oncology, 1997
- Analysis of interobserver and intraobserver variability in CT tumor measurements.American Journal of Roentgenology, 1996